Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis

Many patients with rheumatoid arthritis (RA) require a trial of multiple biologic disease-modifying anti-rheumatic drugs (bDMARDs) to control their disease. With the availability of several bDMARD options, the...

Source: Arthritis Research and Therapy - June 2, 2023 Category: Rheumatology Authors: Priyam Das, Dana Weisenfeld, Kumar Dahal, Debsurya De, Vivi Feathers, Jonathan S. Coblyn, Michael E. Weinblatt, Nancy A. Shadick, Tianxi Cai and Katherine P. Liao Tags: Research Source Type: research